The tumor-promoting activity of NFE2L2 has been attributed to its own function; its activity is generally enhanced in glioblastoma cell lines and tumors, and low NFE2L2 expression inhibits proliferation and self-renewal of glioma stem cells (40, 41). The gene discussed is NFE2L2; the disease is central nervous system cancer.